Verdict . News

Federal Circuit Court of Appeals

1w ago•4 min read

Federal Circuit Affirms BASF Victory in Patent Dispute with Ingevity

The U.S. Court of Appeals for the Federal Circuit decided a patent infringement case between Ingevity Corporation and BASF Corporation on February 11, 2026. The case involved U.S. Patent RE38,844, with the district court having granted summary judgment of invalidity on Ingevity's asserted claims.

•Federal Circuit decided patent dispute between Ingevityand BASF on February 11, 2026

•District court had granted summary judgment invalidating Ingevity's patent claims

•Express Scripts agreed to end practices that artificially inflated prescription drug prices, potentially saving consumers $7 billion over 10 years

1w ago•4 min read

FTC Secures $7B Settlement with Express Scripts Over Drug Pricing

The Federal Trade Commission announced a settlement with Express Scripts that could lower prescription drug prices by up to $7 billion over the next decade. The pharmacy benefit manager agreed to end business practices that artificially inflated drug costs for American consumers.

•The company controls 80% of the prescription drug market with two competitors and accounts for 23% of total prescriptions

•FTC requires Sevita Health to divest 128 intermediate care facilities across Indiana, Louisiana, and Texas

2w ago•4 min read

FTC Orders Sevita to Divest 128 Care Facilities in $835M Merger

The Federal Trade Commission has required Sevita Health to divest 128 intermediate care facilities across Indiana, Louisiana, and Texas to resolve antitrust concerns over its proposed $835 million acquisition of BrightSpring Health Services' community living business. The action prevents the consolidation of the two largest national providers of residential services for individuals with intellectual and developmental disabilities.

•Divestiture resolves antitrust concerns over $835 million acquisition of BrightSpring's community living business

•FTC Chairman sent warning letters to 42 major law firms participating in Mansfield Certification program

2w ago•4 min read

FTC Chairman Warns 42 Major Law Firms on Anticompetitive DEI Hiring

Federal Trade Commission Chairman Andrew N. Ferguson issued warning letters to 42 major law firms participating in the Mansfield Certification program, cautioning that coordinated diversity hiring practices may violate federal antitrust laws. The firms collectively employ over 50,000 attorneys and worked with Diversity Lab to implement standardized DEI criteria across the legal industry.

•Firms allegedly coordinated on DEI hiring standards through Diversity Lab consultancy

Sixth Circuit Court of Appeals

3w ago•4 min read

6th Circuit Issues Decision in Ohio's Lawsuit Against Major PBMs

The U.S. Court of Appeals for the Sixth Circuit has issued a decision in a significant case brought by Ohio Attorney General Dave Yost against major pharmacy benefit managers including Express Scripts, Cigna Group, and Evernorth Health. The case represents a major legal challenge to the practices of pharmaceutical middlemen that manage prescription drug benefits.

•Ohio Attorney General Dave Yost sued five major pharmacy benefit managers including Express Scripts, Cigna Group, and Evernorth Health

•The Sixth Circuit Court of Appeals issued its decision on January 27, 2026, after oral arguments in December 2025

Fifth Circuit Court of Appeals

Jan 14, 2026•2 min read

5th Circuit Revives Antitrust Claims Against Caremark PBM Network

The Fifth Circuit Court of Appeals partially reversed a lower court's dismissal of antitrust claims by Rx Solutions against Caremark LLC and CVS Pharmacy Inc. The appeals court affirmed the dismissal of federal antitrust claims but found diversity jurisdiction exists for state law claims.

•Fifth Circuit affirmed dismissal of federal antitrust claims but reversed district court's diversity jurisdiction finding

•Rx Solutions can proceed with two of three state law claims against Caremark and CVS Pharmacy

Ninth Circuit Court of Appeals

Jan 8, 2026•4 min read

9th Circuit Affirms Apple Win in AliveCor Heart Monitor Antitrust Case

The Ninth Circuit Court of Appeals affirmed a district court's summary judgment in favor of Apple Inc. in an antitrust lawsuit brought by medical technology company AliveCor. The case involved allegations that Apple monopolized the market by changing its Apple Watch heart rate algorithms to disable competing atrial fibrillation detection software.

•Ninth Circuit affirmed district court's summary judgment for Apple in Sherman Act Section 2 monopolization case

•AliveCor's SmartRhythm feature detected atrial fibrillation using Apple Watch heart rate data in Workout Mode

Ninth Circuit Court of Appeals

Jan 8, 2026•4 min read

9th Circuit Revives Seagate Antitrust Claims Against NHK Spring

The Ninth Circuit Court of Appeals vacated a district court's summary judgment and revived antitrust claims by Seagate Technology against Japanese manufacturer NHK Spring Co., Ltd. The case involves allegations of price-fixing in suspension assemblies used in hard drives.

•Ninth Circuit reversed district court's summary judgment dismissing Seagate's Sherman Act claims against NHK Spring

•Case involves price-fixing conspiracy in suspension assemblies used in hard drives, with NHK already pleading guilty in criminal proceeding

•FTC sent warning letters to 13 unnamed property management software companies for potentially hindering accurate rental pricing disclosure

Dec 9, 2025•4 min read

FTC Warns 13 Property Management Software Companies Over Hidden Rental Fees

The Federal Trade Commission issued warning letters to 13 property management software providers nationwide, alleging they may be violating federal law by preventing rental property managers from displaying complete pricing information to consumers. The enforcement action follows the FTC's recent $24 million settlement with Greystar for deceptive pricing practices.

•Software providers allegedly prevent inclusion of mandatory fees in advertised rental prices, harming consumer decision-making